Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8551261rdf:typepubmed:Citationlld:pubmed
pubmed-article:8551261lifeskim:mentionsumls-concept:C0999806lld:lifeskim
pubmed-article:8551261lifeskim:mentionsumls-concept:C0043210lld:lifeskim
pubmed-article:8551261lifeskim:mentionsumls-concept:C0444186lld:lifeskim
pubmed-article:8551261lifeskim:mentionsumls-concept:C0547040lld:lifeskim
pubmed-article:8551261lifeskim:mentionsumls-concept:C0205081lld:lifeskim
pubmed-article:8551261lifeskim:mentionsumls-concept:C0031082lld:lifeskim
pubmed-article:8551261lifeskim:mentionsumls-concept:C1947932lld:lifeskim
pubmed-article:8551261lifeskim:mentionsumls-concept:C1709793lld:lifeskim
pubmed-article:8551261pubmed:issue1lld:pubmed
pubmed-article:8551261pubmed:dateCreated1996-2-20lld:pubmed
pubmed-article:8551261pubmed:abstractTextThe aim of this study was to examine the efficacy of semi-quantitative polymerase chain reaction (PCR) testing in cervical smears as an adjunct to cytological surveillance in a cohort of women with mild or moderate dyskaryosis. The study population comprised a group of 62 women who underwent twelve months of cytological and colposcopic surveillance as part of a larger randomised prospective study of women with mild and moderate dyskaryosis. Semi-quantitative PCR for HPV-16 DNA was carried out on the initial and twelve month study smears before a large loop excision of the transformation zone (LLETZ) was carried out. Smears from a control population which comprised 167 women without a history of abnormal cervical cytology who were attending family planning and general practitioner clinics for routine cervical smears were tested similarly. The presence of high or intermediate levels of HPV-16 DNA on both the initial and twelve month study smear was positively associated with the identification of cervical intraepithelial neoplasia (CIN) grades II or III in the LLETZ specimen (P = 0.01). While the combination of HPV-16 DNA testing with cytology on a repeat cervical smear improved the selection of women with underlying CIN II/III, there was still a false negative rate of 53%. Twenty-nine women had 'low risk' levels of HPV-16 DNA and mild dyskaryosis or less on both repeat smears indicating suitability for surveillance, but in fact 34% of them had CIN II/III. This study supports the finding reported previously of an association between high and intermediate levels of HPV-16 DNA and CIN II/III.(ABSTRACT TRUNCATED AT 250 WORDS)lld:pubmed
pubmed-article:8551261pubmed:languageenglld:pubmed
pubmed-article:8551261pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8551261pubmed:citationSubsetIMlld:pubmed
pubmed-article:8551261pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8551261pubmed:statusMEDLINElld:pubmed
pubmed-article:8551261pubmed:monthSeplld:pubmed
pubmed-article:8551261pubmed:issn0146-6615lld:pubmed
pubmed-article:8551261pubmed:authorpubmed-author:AndersonDDlld:pubmed
pubmed-article:8551261pubmed:authorpubmed-author:MannEElld:pubmed
pubmed-article:8551261pubmed:authorpubmed-author:KitchenerHHlld:pubmed
pubmed-article:8551261pubmed:authorpubmed-author:JiangGGlld:pubmed
pubmed-article:8551261pubmed:authorpubmed-author:FlannellyGGlld:pubmed
pubmed-article:8551261pubmed:authorpubmed-author:MelvinWWlld:pubmed
pubmed-article:8551261pubmed:issnTypePrintlld:pubmed
pubmed-article:8551261pubmed:volume47lld:pubmed
pubmed-article:8551261pubmed:ownerNLMlld:pubmed
pubmed-article:8551261pubmed:authorsCompleteYlld:pubmed
pubmed-article:8551261pubmed:pagination6-9lld:pubmed
pubmed-article:8551261pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8551261pubmed:meshHeadingpubmed-meshheading:8551261-...lld:pubmed
pubmed-article:8551261pubmed:meshHeadingpubmed-meshheading:8551261-...lld:pubmed
pubmed-article:8551261pubmed:meshHeadingpubmed-meshheading:8551261-...lld:pubmed
pubmed-article:8551261pubmed:meshHeadingpubmed-meshheading:8551261-...lld:pubmed
pubmed-article:8551261pubmed:meshHeadingpubmed-meshheading:8551261-...lld:pubmed
pubmed-article:8551261pubmed:meshHeadingpubmed-meshheading:8551261-...lld:pubmed
pubmed-article:8551261pubmed:meshHeadingpubmed-meshheading:8551261-...lld:pubmed
pubmed-article:8551261pubmed:meshHeadingpubmed-meshheading:8551261-...lld:pubmed
pubmed-article:8551261pubmed:meshHeadingpubmed-meshheading:8551261-...lld:pubmed
pubmed-article:8551261pubmed:meshHeadingpubmed-meshheading:8551261-...lld:pubmed
pubmed-article:8551261pubmed:meshHeadingpubmed-meshheading:8551261-...lld:pubmed
pubmed-article:8551261pubmed:meshHeadingpubmed-meshheading:8551261-...lld:pubmed
pubmed-article:8551261pubmed:meshHeadingpubmed-meshheading:8551261-...lld:pubmed
pubmed-article:8551261pubmed:meshHeadingpubmed-meshheading:8551261-...lld:pubmed
pubmed-article:8551261pubmed:year1995lld:pubmed
pubmed-article:8551261pubmed:articleTitleSerial quantitation of HPV-16 in the smears of women with mild and moderate dyskaryosis.lld:pubmed
pubmed-article:8551261pubmed:affiliationWellbeing Centre for the Prevention of Cervical Cancer, Aberdeen Royal Infirmary, University of Aberdeen, Scotland.lld:pubmed
pubmed-article:8551261pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8551261lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8551261lld:pubmed